|
Category:emollients, emulsifiers
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 531.00 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 316.00 °F. TCC ( 158.00 °C. ) (est)
|
| logP (o/w): | 9.741 (est) |
| Soluble in: |
| | water, 6.33e-005 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | emollients, emulsifiers |
| Recommendation for glyceryl dilaurate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for glyceryl dilaurate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
| | emollients |
| | emulsifying agents |
Occurrence (nature, food, other): note
Synonyms:
| | dialaurin | | 1,2- | didodecanoylglycerol | | rac-1,2- | didodecanoylglycerol | | | dilaurin | | 1,2- | dilaurin | | 2,3- | dilauroyl-D-glycerol | | 1,2- | dilauroyl-sn-glycerol | | | dodecanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester | | | dodecanoic acid, diester with 1,2,3-propanetriol | | (2- | dodecanoyloxy-3-hydroxypropyl) dodecanoate | | 2-( | dodecanoyloxy)-1-(hydroxymethyl)ethyl laurate | | | hallstar GDL | | 3- | hydroxypropane-1,2-diyl didodecanoate | | | lauric acid diester with glycerol | | | lauric acid, diester with glycerol | | | lonzest GDL |
Articles:
| PubMed:Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers. |
| PubMed:Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate. |
| PubMed:In-vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique--relation to duration of action in-vivo. |
| PubMed:Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. |
| PubMed:Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. |
|
3D/inchi